BFC Planning’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$291 Hold
9
– – ﹤0.01% 3332
2026
Q2
$386 Hold
9
– – ﹤0.01% 3277
2026
Q1
$362 Hold
9
– – ﹤0.01% 2892
2025
Q4
$456 Hold
9
– – ﹤0.01% 2942
2025
Q3
$262 Buy
+9
New +$208 ﹤0.01% 2806

Other funds holding VERA

BFC Planning's VERA Position: Q3 2026 in Review

BFC Planning held its Vera Therapeutics (VERA) position steady in Q3 2026 at 9 shares worth $291. The position accounts for ﹤0.01% of the portfolio, ranked #3332.

BFC Planning first reported a position in VERA in Q3 2025 and has held it in 5 quarters since. The position peaked at $456 in Q4 2025. 147 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • BFC Planning held 9 shares of Vera Therapeutics worth $291 as of Q3 2026.
  • BFC Planning left its Vera Therapeutics share count unchanged in Q3 2026.
  • Vera Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3332 holding.
  • BFC Planning first reported a position in Vera Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • BFC Planning's Vera Therapeutics position peaked at $456 in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.